Delivery Order SPE2DR25D1004-SPE2DR26FSTY6
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,781.10 on August 8, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors with a completion date of August 11, 2025. This competitive award, which utilized firm fixed-price pricing with no set-aside designation, represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors valued at $2,702.70, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,502.55 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on October 24, 2025, with completion expected by October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors, with a contract ceiling value of $1,072.35 and an ultimate completion date of September 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $1,218.01, with completion scheduled for August 22, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical transaction within the broader federal medical supply chain. The contract specifies performance at AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,228.84 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This firm fixed-price contract, which is a child order under a larger indefinite delivery vehicle, represents a non-competitive set-aside and is scheduled for completion by August 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $2,700.77. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was awarded on a non-competitive basis as part of a broader procurement relationship between DLA and the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,435.89. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSTY6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $2,325.92, with completion targeted for October 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency and U.S. Coast Guard. Trulicity is a diabetes medication commonly utilized within military and veteran healthcare systems, reflecting the critical pharmaceutical support AmerisourceBergen provides across the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 10/24/25 |